Use of thiopyrimidinecarboxamide for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9707248
SERIAL NO

15279361

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is disclosed is a method of treating cancer using compound having formula SX-682

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTRIX BIOSYSTEMS INCWASHINGTON DC WASHINGTON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Maeda, Dean Y Seattle, US 19 121
Schuler, Aaron D Auburn, US 12 73
Zebala, John A Issaquah, US 38 403

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00